Analysts expect Dyne Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.35 M | 7.61 M | 8.98 M | 8.53 M | 61.13 M | 78.63 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.87 M | 6.99 M | 8.32 M | 7.88 M | 51.31 M | 69.89 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.11 M | 7.30 M | 8.65 M | 8.21 M | 56.22 M | 74.26 M |
Analysts expect Dyne Therapeutics, Inc. to report earnings per share of -0.94 for Q3 26, against a range of -0.99 to -0.89. The most recent reported quarter, Q2 26, came in at -1.08, a 36.7% miss against the -0.79 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.96 | -0.88 | -1.05 | -0.97 | -0.76 | -0.76 | -0.73 | -1.08 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.61 | -0.94 | -0.75 | -0.84 | -0.84 | -0.74 | -0.76 | -0.75 | -0.89 | -0.86 | -0.77 | -0.75 | -0.73 | -0.73 | -0.69 | -0.65 | ||||||||||
| Low Estimate | -0.71 | -1.02 | -0.89 | -0.94 | -0.92 | -0.86 | -0.82 | -0.83 | -0.99 | -1.00 | -0.89 | -0.91 | -0.87 | -0.81 | -0.79 | -0.71 | ||||||||||
| Consensus Estimate | -0.66 | -0.98 | -0.82 | -0.89 | -0.88 | -0.80 | -0.79 | -0.79 | -0.94 | -0.93 | -0.83 | -0.83 | -0.80 | -0.77 | -0.74 | -0.68 |
Pull Wall Street consensus for Dyne Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=DYN&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "DYN", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=DYN&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();